HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masataka Kuwana Selected Research

Polymyositis

11/2022Branched chain amino acids in the treatment of polymyositis and dermatomyositis: a phase II/III, multi-centre, randomized controlled trial.
1/2022Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan.
1/2020Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease.
1/2018Association of Serum Soluble CD163 with Polymyositis and Dermatomyositis, Especially in Anti-MDA5 Antibody-positive Cases.
1/2017Sarcoplasmic MxA expression: A valuable marker of dermatomyositis.
11/2016A unique case of polymyositis with anti-signal recognition particle antibody complicated by subacute interstitial lung disease and subluxing arthropathy, resembling anti-synthetase syndrome.
1/2016Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in Japan.
9/2015Distinct profiles of myositis-specific autoantibodies in Chinese and Japanese patients with polymyositis/dermatomyositis.
12/2014Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
5/2012Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masataka Kuwana Research Topics

Disease

61Interstitial Lung Diseases (Interstitial Lung Disease)
11/2022 - 06/2004
47Systemic Scleroderma (Systemic Sclerosis)
02/2022 - 10/2002
41Dermatomyositis (Dermatopolymyositis)
11/2022 - 06/2004
32Myositis (Idiopathic Inflammatory Myopathies)
01/2022 - 08/2007
31Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 04/2002
25Melanoma (Melanoma, Malignant)
06/2022 - 07/2009
16Rheumatoid Arthritis
04/2022 - 01/2006
16Connective Tissue Diseases (Connective Tissue Disease)
11/2020 - 12/2003
14Pulmonary Arterial Hypertension
11/2022 - 01/2010
14Autoimmune Diseases (Autoimmune Disease)
02/2022 - 04/2003
12Polymyositis
11/2022 - 10/2005
11Fibrosis (Cirrhosis)
10/2020 - 06/2003
10Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2019 - 08/2002
9Thrombocytopenia (Thrombopenia)
01/2022 - 08/2002
9Amyopathic dermatomyositis
01/2022 - 05/2005
8Infections
10/2020 - 02/2005
8Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2018 - 04/2002
7Diffuse Scleroderma (Progressive Systemic Sclerosis)
11/2022 - 03/2007
7Neoplasms (Cancer)
07/2019 - 01/2010
6Idiopathic Pulmonary Fibrosis
01/2021 - 05/2005
6Disease Progression
10/2020 - 01/2010
6Myasthenia Gravis
08/2011 - 04/2003
5Muscle Weakness
05/2022 - 09/2014
5Muscular Diseases (Myopathy)
01/2017 - 01/2009
5Thrombosis (Thrombus)
10/2014 - 01/2003
5Thymoma (Thymic Carcinoma)
05/2013 - 12/2003
4Aplastic Anemia (Anemia, Hypoplastic)
01/2022 - 09/2005
4Mixed Connective Tissue Disease (MCTD)
01/2021 - 10/2012
4Hemorrhage
01/2020 - 06/2004
4Atrophy
01/2017 - 12/2005
4Inflammation (Inflammations)
01/2015 - 01/2009
4Pemphigus (Pemphigus Vulgaris)
09/2011 - 02/2007
3Diarrhea
03/2021 - 01/2019
3Purpura
01/2020 - 08/2003
3Joint Diseases (Joint Disease)
11/2016 - 10/2013
3Behcet Syndrome (Behcet's Syndrome)
02/2015 - 11/2004
3Bronchiolitis Obliterans Syndrome
03/2007 - 10/2003
2Arthritis (Polyarthritis)
11/2022 - 03/2019
2Takayasu Arteritis (Arteritis, Takayasu's)
11/2022 - 12/2018
2Rheumatic Diseases (Rheumatism)
04/2022 - 03/2021
2Virus Diseases (Viral Diseases)
01/2022 - 07/2009
2COVID-19
01/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

76AutoantibodiesIBA
06/2022 - 04/2002
41AntibodiesIBA
06/2022 - 08/2002
27Inosine Triphosphate (ITP)IBA
01/2022 - 08/2002
19Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
06/2022 - 05/2007
16EnzymesIBA
06/2022 - 08/2002
14Biomarkers (Surrogate Marker)IBA
10/2021 - 05/2009
12Immunoglobulin G (IgG)IBA
01/2016 - 01/2003
11ImmunosorbentsIBA
06/2022 - 08/2002
11Proteins (Proteins, Gene)FDA Link
06/2022 - 12/2003
9tocilizumab (atlizumab)FDA Link
11/2022 - 01/2010
9nintedanibIBA
01/2022 - 01/2019
9AntigensIBA
11/2014 - 08/2002
8Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 12/2003
8Signal Recognition ParticleIBA
07/2017 - 09/2005
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 12/2010
7Ferritins (Ferritin)IBA
06/2018 - 04/2011
6Monoclonal AntibodiesIBA
09/2021 - 01/2003
6Interleukin-6 (Interleukin 6)IBA
10/2020 - 01/2010
6Peptides (Polypeptides)IBA
03/2019 - 04/2003
5Mi-2 antibodiesIBA
06/2022 - 04/2011
5Pharmaceutical PreparationsIBA
02/2022 - 01/2010
5Thrombopoietin (c-mpl Ligand)IBA
01/2022 - 08/2002
5transcriptional intermediary factor 1IBA
01/2020 - 09/2012
5CytokinesIBA
01/2019 - 03/2004
5beta-cyclodextrin tetradecasulfate (CTDS)IBA
12/2016 - 05/2005
5Intravenous Immunoglobulins (IVIG)FDA Link
01/2016 - 04/2006
4RNA (Ribonucleic Acid)IBA
06/2022 - 09/2014
4Ligases (Synthetase)IBA
02/2022 - 06/2004
4Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2021 - 06/2004
4AutoantigensIBA
09/2011 - 06/2003
4beta 2-Glycoprotein I (Apolipoprotein H)IBA
12/2007 - 04/2002
4Cholinergic ReceptorsIBA
08/2007 - 04/2003
3Immunoglobulin M (IgM)IBA
05/2022 - 04/2006
3Biological ProductsIBA
04/2022 - 01/2010
3Calcineurin InhibitorsIBA
01/2022 - 04/2018
3Immunosuppressive Agents (Immunosuppressants)IBA
03/2021 - 10/2003
3Rituximab (Mabthera)FDA Link
01/2021 - 11/2004
3GlucocorticoidsIBA
05/2020 - 01/2015
3Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
01/2020 - 06/2018
3InterleukinsIBA
01/2019 - 03/2004
3HLA-DRB1 Chains (HLA DRB1)IBA
09/2017 - 01/2006
3Bosentan (Tracleer)FDA Link
01/2017 - 10/2011
3RNA Polymerase IIIIBA
01/2017 - 10/2002
3erucylphosphocholineIBA
02/2015 - 12/2010
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 03/2004
3Epoprostenol (Prostacyclin)FDA LinkGeneric
01/2015 - 11/2013
3DesmogleinsIBA
09/2011 - 07/2008
3Glycoproteins (Glycoprotein)IBA
11/2004 - 01/2003
2RibonucleoproteinsIBA
06/2022 - 01/2021
2MethylprednisoloneFDA LinkGeneric
05/2022 - 03/2021
2Antirheumatic Agents (DMARD)IBA
04/2022 - 09/2017
2VaccinesIBA
01/2022 - 01/2022
2Tyrosine Kinase InhibitorsIBA
09/2021 - 01/2019
2anti-scl-70 autoantibodiesIBA
09/2021 - 01/2017
2Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
09/2021 - 01/2010

Therapy/Procedure

26Therapeutics
01/2022 - 10/2003
3Hematopoietic Stem Cell Transplantation
01/2014 - 10/2003
3Transplantation
02/2012 - 12/2006